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Abstract 
Carcinoma breast comprises 22.9% of invasive cancers in female and 16% of all female cancers. Worldwide breast cancer causes 
13.7% of cancer deaths in women and 6.0% of all cancer deaths for men and women together. 55% of breast cancer is invasive 
ductal carcinoma. BCS followed by radiation therapy to the intact breast is most acceptable standard of care for the early stage 
invasive breast cancer. Various radiotherapy techniques are used for breast irradiation. Precise and accurate delivery of radiation to 
the target volume reduces the relapse and increases the overall survival. 50 patients of early breast cancer with age range of 20-
60yrs, who received radiotherapy as a treatment modality, were included in the study. Radiotherapy treatment procedure was 
analyzed and advantage of different radiotherapy parameters were compared on basis of side effects recorded. Median age of the 
patients was 45yrs and 70% were of stage-II breast cancer. 44% patients were treated with bolus and 56% were treated without any 
accessory. 46% minor side effects were recorded after radiotherapy treatment. There was no simulation and verification system for 
evaluation of radiotherapy treatment, because of lack of facility in the department. It is concluded that there must be availability of all 
the radiotherapy treatment parameters including simulation, accessories and treatment verification system for accurate delivery of 
radiotherapy. These parameters can also reduce the side effects of radiotherapy and increase the beneficial ratio of radiotherapy.  
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INTRODUCTION 
Cancer of the breast ranks as one of the first recorded 
cancers in humans and today it is the leading cause of 
cancer death among females (Wynder et al., 1960; Ferlay 
et al., 2010). Breast cancer comprises 22.9% of invasive 
cancers in female and 16% of all female cancers (World 
Cancer Report, 2008). Approximately 42% cases of breast 
cancer occur in the developing countries. Worldwide breast 
cancer causes 13.7% of cancer deaths in women and 
6.0% of all cancer deaths for men and women together. In 
Pakistan breast cancer accounts for one-third of the 
cancers in the females (Bhurgri et al., 2000). 
Breast cancer is usually classified primarily by its 
histological appearance. Most of the breast cancers are 
classified as ductal or lobular carcinoma. In contrast, 
invasive carcinoma does not confine itself to the initial 
tissue compartment. Carcinoma breast is diagnosed 
initially by Fine Needle Aspiration (FNA), Core Needle 
Biopsy (CNB), Vacuum-assisted Core Needle Biopsy 
(VAB), USG and biopsy. Non-palpable mass is diagnosed 
by excisional biopsy, stereotactic and ultrasound guided 
core biopsies, breast MRI, USG and chest radiographs. 
Metastatic workup of breast carcinoma includes bone scan, 
liver scan and brain scan (CDC, 2016). 
 Treatment of early breast cancer after diagnosis and 
staging is surgery followed by systemic therapy which 
includes chemotherapy, radiotherapy and/or hormonal 
therapy to improve the chances of recovery. Surgery 
involves breast-conserving surgery, Lumpectomy and 
Mastectomy. Whereas in locally advanced breast cancer 
(LABC) Stage-III disease, neo-adjuvant chemotherapy is 
given followed by mastectomy. If tumor shows good results 
than radiation therapy is given otherwise 2 more cycles of 
chemotherapy are given before radiotherapy. According to 
the ERPR status hormone therapy is given. Different 
cancers respond differently to radiation therapy (Bomford et 
al., 2002). Optimal radiotherapy utilization rate for breast 
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cancer is 83%. Recently, there have been a number of 
randomized trials evaluating optimal approaches to the 
delivery of radiation therapy after BCS (Breast-Conserving 
Surgery) (Bartelink et al., 2001). Ali et al. (2015) 
demonstrated that mutation is responsible for causing 
Hepatocellular carcinoma cancer. 
Various radiotherapy techniques are used for breast 
irradiation. These techniques include Multifield Breast 
Fields “tangential fields to chest wall and Supraclavicular 
field (anterior)”, IMRT (Pingol et al., 2008)
 
(Intensity 
Modulated Radiotherapy) and Proton therapy (Ares et al., 
2010). Moreover breast cancer is also radiated by internal 
radiotherapy and Intraoperative radiotherapy. 
Intraoperative therapy is given after BCS usually in ductal 
carcinoma in situ (DCIS). In brachytherapy or implantation 
therapy, implantation seeds of radioactive material are 
inserted inside the breast and radiation dose is delivered in 
contact with the tissue. There are a number of radiotherapy 
induced side effects after radiating the breast cancer which 
may be short term or long term side effects. Accurate and 
precise radiation treatment planning and execution of the 
plan can reduce the risk of these side effects. 
This research elaborated the parameters which are 
necessary for accurate and reproducible delivery of 
radiation therapy in patients of early breast cancer. 
 
MATERIALS AND METHODS 
Materials and Subjects 
Patients of early breast cancer 
Questionnaire   
Sampling technique 
Non-probability sampling technique (Convenience 
Sampling) 
Study design 
Observational Study Design (Retrospective) 
Sample size 
Fifty patients 
Sample Selection 
Inclusion criteria 
Patients in age range of 20-60yrs 
Patients of stage-I and stage-II 
All the patients with BCS as well as MRM 
Patients diagnosed on histopathological basis 
Patients with WHO performance status of 0-3 
Exclusion criteria 
Patients above the age of 60yrs 
All the patients of stage-0, stage-III and stage-IV 
Patients with WHO performance status of 4 and 5 
Data Collection Procedure 
This study was conducted in Clinical Oncology 
Department Mayo Hospital Lahore. In this study 
parameters for accurate radiotherapy in patients of early 
breast cancer were elaborated which mainly include dose 
calibration, depth dose, precise patient geometric 
positioning during treatment of radiation, simulation, 
dosimetry, treatment units and treatment verification. The 
respective variables were defined to evaluate the 
radiotherapy treatment and different parameters required 
for reproducible delivery of radiotherapy. These variables 
include: age, disease site (right or left breast), stage, 
treatment modalities used, indications of radiotherapy, 
accessories used during radiation treatment and side 
effects observed after irradiation. Whole study was 
conducted under the ethical considerations of WMA 
declaration of Helsinki and it was preceded according to 
the rules of ethical review board (ERB) of Mayo Hospital 
Lahore. 
Data Analysis 
For qualitative variables descriptive statistics were used 
which include percentages and proportion using SPSS 
version 16. 
 
RESULTS 
The results showed that maximum patients included in 
the study were 45yrs of age 30%. While 20% patients were 
of 50yrs and 16% were 40yrs of age. Minimum age was 
24yrs and maximum was 60yrs. The mean of patients’ 
ages was 45±8.90 (Table 1). 
 
Table 1. Prevalence of breast cancer among various 
ages. 
Age Frequency %age Cumulative 
Percentage 
Mean
±S.D 
60 5 10 10 
4
5
±
8
.9
0
 
55 6 12 22 
50 10 20 42 
45 15 30 72 
40 8 16 88 
33 2 4 92 
30 1 2 94 
25 2 4 98 
24 1 2 100 
Total 50 100  
 
Our results showed that 30% patients were of stage-I 
and 70% patients of stage-II breast cancer (Figure 1). 
 
 
Fig. 1. Stage wise distribution of breast cancer 
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The results of our study showed that 42% patients 
have disease in left breast and 58% have right sided breast 
carcinoma (Figure 2). 
 
 
 
 
Fig. 2. Location of breast carcinoma 
 
This study results showed that 42% patients have 
received radiotherapy only on chest wall while 58% have 
received RT on both chest wall and SCF (Table 2). 
 
Table 2. Field of radiotherapy 
Field Frequency %age Cumulative 
Percentage 
Mean
±S.D 
CWRT 21 42.0 42.0 
2
.1
6
±
0
.9
9
 
CWRT
+SCF 
29 58.0 100 
Total 50 100  
 
 
This study showed that 10 patients 20% were treated 
with surgery and radiotherapy, 23 patients 46% with 
surgery, chemotherapy and radiotherapy, only 4 patients 
8% received hormone therapy after surgery and 
radiotherapy and 12 patients 24% were treated with all four 
modalities including surgery, radiotherapy, chemotherapy 
and hormone therapy (Table 3). 
 
 
Table 3. Treatments used for breast cancer. 
 
 
Treatment 
F
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C
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v
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P
e
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e
n
t 
M
e
a
n
±
S
.D
 
Valid   SG+RT 10 20 20.4 20.4 
3
.6
1
±
1
.4
6
 
            SG+ CT    
            + RT 
23 46 46.9 67.3 
            SG+RT+  
            HT 
4 8 8.2 75.5 
            SG+CT+  
            RT+HT 
12 24 24.5 100.0 
           Total 49 98 100  
Missing System 1 2   
Total 50 100   
*SG: Surgery, RT: Radiotherapy, CT, Chemotherapy, HT: 
Hormone therapy 
 
The results of our study showed that 23 patients 46% 
with tumor size greater that 5cm (T3) were indicated for RT, 
17 patients 34% have multiple nodal involvement, 7 
patients 14% were indicated on BCS basis and 2 patients 
4% only on basis of stage-I breast cancer (Table 4). 
 
Table 4. Indications for radiotherapy of breast cancer 
 
 
Indications 
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P
e
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Valid BCS 7 14 14.3 14.3 
 STAGE-I 2 4 4.1 18.4 
 Tumor>5cm 23 46 46.9 65.3 
 Multiple nodal 
involvement 
17 34 34.7 100 
 Total 49 98 100  
Missing 
System 
 1 2   
Total  50 100   
*BCS: Breast-Conserving Surgery 
 
The results showed that 22 patients (44%) of early 
breast cancer were irradiated using bolus, 28 patients 
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(56%) were irradiated without any accessory and no patient 
0% was treated using breast board (Table 5). 
 
Table 5. Assessories for treatment of breast cancer 
Accessories Frequency %age Cumulative 
Percentage 
Bolus 22 44.0 42.0 
No 28 56.0 100 
Total 50 100  
 
Our study demonstrated that there were complications in 
23 patients (46%) in which 15 patients (30%) showed skin 
burning (erythema) and 8 patients (16%) represented with 
recurrent chest wall disease, while 27 patients (54%) 
represented with no complications after radiotherapy (Table 
6). 
 
Table 6. Complications after radiotherapy of breast 
cancer 
Complications Frequency %age Cumulative 
Percentage 
Skin burning 15 30 30 
Recurrent chest 
wall disease 
8 16 46 
None 27 54 100 
Total 50 100  
 
DISCUSSION 
Role of radiotherapy in the treatment of early breast 
cancer has a long and controversial history (Paterson and 
Russel, 1959). There is enough evidence available which 
demonstrates that radiotherapy reduces the local relapse 
rate. However, there is reduction in relapse rate not in 
mortality rate of the breast cancer patient (Stjern, 1997). 
Ancient reports of Rutqvist et al. (1992)
 
and Cuzik et al. 
(1994)
 
clearly demonstrated that deaths of breast cancer 
patients were potentially due to cardiac deaths not because 
of breast disease. It was proved by many larger 
subsequent trials that radiotherapy was causing cardiac 
deaths (Early Breast Cancer Trialists' Collaborative Group, 
2000). 
This published data strongly proposed that 
radiotherapy is best treatment modality for breast cancer, 
but to reduce the harmful risks of radiotherapy to heart, 
other vital and sensitive structures, there must be certain 
changes in the administration of radiotherapy, so that there 
is reduced mortality rate. Radiation Oncologists modify the 
radiotherapy planning, field portals and plan execution 
method; these factors greatly reduced the cardiac disease. 
In recent trials breast cancer breast cancer deaths are 
indeed reduced (Overgaard et al., 1997; Hojris et al., 1999). 
Recent data suggests that radiotherapy after mastectomy 
or breast conserving surgery BCS has beneficial effect on 
survival (Vin-Hungh and Verschraegen, 2004). 
Three randomized clinical trials of post mastectomy 
radiotherapy (Overgaard et al., 1997; Regaz et al., 1997; 
Overgaard et al., 1999), have shown 9%-10% 
improvement in overall survival after 10yrs, for patients who 
received radiotherapy compared with those patients who 
do not receive radiotherapy. 
In Canadian and Danish trials it is proved that 
radiotherapy given to the loco regional sites prevent 
dissemination, thus being the potentially protective 
modality. According to the randomized clinical trials of 
adjuvant radiotherapy, the radiotherapy administered after 
breast conserving surgery BCS, has favorable effects on 
survival (Whelan et al., 2000). 
Multiple trials have shown a substantial risk of local 
recurrence, if radiotherapy is omitted after breast 
conserving surgery BCS. Analysis of registry data by some 
authors (Vin-Hungh and Verschraegen, 2004; Vin-Hungh et 
al., 2003; Vallis et al., 2002), suggests large survival benefit 
from use of radiotherapy after breast conserving surgery 
BCS. Radiotherapy in intact breast with modern techniques 
reduces the cardiac toxicity. In addition high precision 
radiotherapy techniques such as intensity modulated 
radiotherapy IMRT, 3-D conformal radiation therapy, partial 
breast irradiation PBI etc. improve the benefits ratio of 
using radiotherapy. The meta-analysis presented by Vinh 
Hungh et al. (2003) reinforces the view that patients 
undergoing BCS should also receive radiotherapy. These 
trials proved that irradiation in early breast cancer not only 
reduces the relapse rate but also improves the overall 
survival OS. Alongside radiotherapy various medicinal 
plants have also been used to treat cancer due to their anti-
tumor activity. Al- Mahweety (2016) isolated four 
compounds from resin of Dracaenaceae plant famous for 
their anti-tumor activity. 
This study on Parameters of radiotherapy techniques 
in early breast cancer revealed that with certain 
parameters, radiotherapy can accurately be given to breast 
and chest wall with large benefits ratio of radiotherapy and 
minimum side effects. 
 
CONCLUSION 
In this study the sample size was 50 patients with early 
breast cancer including stage-I and stage-II disease. 
The mean age of the patients in the study was 45yrs 
and 58% were having disease in right breast. 35 patients 
70% were of stage-II breast cancer while 15 patients 30% 
were having stage-I breast cancer. 29 patients 58% 
received CWRT as well as SCF, 21 patients 42% received 
only CWRT. 23 patients 46% received surgery, 
radiotherapy and chemotherapy as treatment modalities. 
22 patients 44% irradiated using bolus, 56% without bolus 
and no patient was irradiated using alpha cradle. 23 
patients 46% represented with side effects after 
radiotherapy, these patients were irradiated without any 
accessory. There was no simulation and port filming of the 
patients because of lack of facility. 
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RECOMMENDATIONS 
The research on parameters of radiotherapy 
techniques elaborated various essential radiotherapy 
techniques and parameters for accurate radiotherapy in 
patients of early breast cancer. 
This study revealed that patients irradiated without 
these parameters, may represent with radiotherapy side 
effects after irradiation. Although the percentage of patients 
with no side effects is higher as compared to the patients 
who complained for acute side effects of radiotherapy. To 
reduce the number of effected patients after radiotherapy 
treatment, following features are recommended according 
to the study: 
 Patient must be simulated before treatment, so 
that any geometric uncertainties regarding 
treatment volume may be removed 
 Complications of the skin can be removed by using 
such accessories and radiotherapy techniques 
 Patients with superficial disease and BCS must be 
irradiated after using bolus 
 For monitoring and accurate delivery of planned 
radiotherapy treatment to the patient, there must 
be treatment verification system. PFI (port filming) 
is most common. 
These parameters will enhance the quality and 
reproducibility of radiotherapy treatment. 
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